UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 OR 15(d) of
                       The Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported) October 14, 2005


                               SWISS MEDICA, INC.
             (Exact name of registrant as specified in its charter)


          Delaware                    000-09489                98-0355519
(State or other jurisdiction         (Commission              (IRS Employer
       of incorporation)             File Number)          Identification No.)


                  53 Yonge Street, 3rd Floor                    M5E 1J3
                   Toronto, Ontario, Canada
           (Address of principal executive offices)           (Zip Code)

            Registrant's telephone number, including area code (416) 868-0202

--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))


<PAGE>

This Form 8-K and other reports filed by Swiss Medica, Inc. (the "Registrant" or
the "Company")  from time to time with the  Securities  and Exchange  Commission
(collectively the "Filings")  contain forward looking statements and information
that are based upon  beliefs of, and  information  currently  available  to, the
Registrant's  management  as  well  as  estimates  and  assumptions  made by the
Registrant's  management.  When  used in the  Filings  the  words  "anticipate",
"believe",  "estimate",  "expect", "future", "intend", "plan" or the negative if
these terms and similar  expressions  as they  relate to the  Registrant  or the
Registrant's  management  identify forward looking  statements.  Such statements
reflect the current view of the Registrant with respect to future events and are
subject to risks,  uncertainties,  assumptions and other factors relating to the
Registrant's  industry,  operations and results of operations and any businesses
that may be  acquired  by the  Registrant.  Should one or more of these risks or
uncertainties materialize, or should the underlying assumptions prove incorrect,
actual  results  may  differ  significantly  from those  anticipated,  believed,
estimated, expected, intended or planned.

Item 1.01 Entry into a Material Definitive Agreement.

Pursuant to a Note and Warrant  Purchase  Agreement dated as of October 28, 2005
by and between the Registrant and Strategic Equity Fund, LP  ("Purchaser"),  the
Company  issued and sold a secured  promissory  note  ("Note") in the  principal
amount of $660,000 CAD ($560,000 USD) to Purchaser on November 2, 2005 that pays
interest  at a rate of 2% per month.  The Note is  secured  by the  Registrant's
personal  property  presently and hereafter  owned,  subject to current security
interests.  The Note is due and  payable on April 28,  2006.  In  addition,  the
Registrant issued to Purchaser  warrants  ("Warrants") to purchase 50,000 shares
of its common stock at $0.20 per share that expire on the fifth  anniversary  of
the issuance date, and 150,000 shares of its common stock ("Common Stock").

Item 2.03 Creation of a Direct  Financial  Obligation or an Obligation  under an
Off-Balance Sheet Arrangement of a Registrant.

      (a)   Disclosure of direct financial obligation.

            (1)   On November 1, 2005,  the Registrant  became  obligated to pay
                  Purchaser amounts due under a 2% per month secured note in the
                  principal  amount of $660,000 CAD ($560,000 USD) due April 28,
                  2006.  The  details  of this Note are  described  in Item 1.01
                  listed above.

            (2)   The  principal  amount of the Note is $660,000  CAD  ($560,000
                  USD) and  interest  accrues at 2% per  month.  The Note may be
                  prepaid at any time. Interest payments of $13,200 CAD ($11,000
                  USD) shall accrue each month. If the Registrant  fails to make
                  any payment as provided herein and such failure  continues for
                  a period of 10 days after  receipt of notice of default,  then
                  the Purchaser may accelerate all payment obligations due under
                  the Note.

            (3)   Under an amendment to a Security  Agreement  dated October 28,
                  2005, the Note is secured by the personal property,  presently
                  and  hereafter   acquired,   including   without   limitation,
                  accounts,   inventory   and   receivables,   subject   to  the
                  Registrant's pre-existing security interests, subject to prior
                  security interests.  Other material provisions of the Note are
                  set forth under Item 1.01.

      (b)   Off-Balance Sheet Arrangement: None

Item 3.02 Unregistered Sale of Equity Securities.

The Company issued the Note, Common Stock and Warrants described under Item 1.01
to the  Purchaser  on November 1, 2005.  The  issuance of these  securities  was
exempt from registration under Section 4(2) of the Securities Act of 1933.


<PAGE>

Item 5.03 Amendments to Certificate of Incorporation or Bylaws

      Pursuant to a  shareholder's  consent (14C) filed on August 26, 2005,  the
Registrant  filed  on  October  14,  2005 an  amendment  to its  Certificate  of
Incorporation to (1) increase the authorized  number of shares of Class A Common
Stock from 100,000,000 to 200,000,000,  (2) to decrease the authorized number of
shares of Class B Common Stock from 50,000,000 to 5,000,000 and (3) to leave the
authorized  number of shares of preferred  stock  unchanged at 10,000,000,  such
that the total number of authorized shares of the Corporation's capital stock is
increased from 160,000,000 to 215,000,000.

Item 8.01 Other Events.

      On  October  21,  2005,  Thomas  Quinn,   Executive  Vice  President,   US
Operations,   ceased  to  be  an  employee  of  the   Registrant.   Mr.  Quinn's
responsibilities  have been jointly assumed by Grant Johnson,  the  Registrant's
President, and Wendy Kramer, the Registrant's Vice President.

Item 9. Financial Statements and Exhibits

(a) Financial Statements of Businesses Acquired.

Not applicable.

(b) Pro Forma Financial Information

Not applicable

(c) Shell Company Transactions

Not applicable

(d) Exhibits.

Exh. No.    Description
--------    -----------

10.1.       Note and Warrant  Purchase  Agreement by and between  Registrant and
            Strategic Equity Corp. dated October 28, 2005

10.2.       Form of Secured Note

10.3.       Form of Warrant

10.4.       Security  Agreement  Amendment No. 3 by and between  Registrant  and
            Strategic Equity Corp. dated October 28, 2005


<PAGE>

                                   SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                        SWISS MEDICA, INC.
                                           (Registrant)

Date: November 7, 2005
                                        /s/ Bruce Fairbairn
                                        ----------------------------------
                                        Bruce Fairbairn, Chief Financial Officer
{"company-data": {"conformed-name": "SWISS MEDICA INC", "cik": "0000318245", "assigned-sic": "2834", "irs-number": "980355519", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-09489", "film-number": "051215387"}, "business-address": {"street1": "53 YONGE STREET, 3RD FLOOR", "street2": "TORONTO", "city": "ONTARIO, CANADA", "state": "A1", "zip": "M5E 1J3", "phone": "416-657-4134"}, "mail-address": {"street1": "53 YONGE STREET, 3RD FLOOR", "street2": "TORONTO", "city": "ONTARIO, CANADA", "state": "A1", "zip": "M5E 1J3"}, "former-company": [{"former-conformed-name": "SWISS MEDIA INC", "date-changed": "20030702"}, {"former-conformed-name": "GLOBAL PATH INC", "date-changed": "20010814"}, {"former-conformed-name": "YOURNET INC/", "date-changed": "19991108"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 OR 15(d) of
                       The Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported) October 14, 2005

                               SWISS MEDICA, INC.
             (Exact name of registrant as specified in its charter)

          Delaware                    000-09489                98-0355519
(State or other jurisdiction         (Commission              (IRS Employer
       of incorporation)             File Number)          Identification No.)

                  53 Yonge Street, 3rd Floor                    M5E 1J3
                   Toronto, Ontario, Canada
           (Address of principal executive offices)           (Zip Code)

            Registrant's telephone number, including area code (416) 868-0202

--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))
This Form 8-K and other reports filed by Swiss Medica, Inc. (the "Registrant" or
the "Company")  from time to time with the  Securities  and Exchange  Commission
(collectively the "Filings")  contain forward looking statements and information
that are based upon  beliefs of, and  information  currently  available  to, the
Registrant's  management  as  well  as  estimates  and  assumptions  made by the
Registrant's  management.  When  used in the  Filings  the  words  "anticipate",
"believe",  "estimate",  "expect", "future", "intend", "plan" or the negative if
these terms and similar  expressions  as they  relate to the  Registrant  or the
Registrant's  management  identify forward looking  statements.  Such statements
reflect the current view of the Registrant with respect to future events and are
subject to risks,  uncertainties,  assumptions and other factors relating to the
Registrant's  industry,  operations and results of operations and any businesses
that may be  acquired  by the  Registrant.  Should one or more of these risks or
uncertainties materialize, or should the underlying assumptions prove incorrect,
actual  results  may  differ  significantly  from those  anticipated,  believed,
estimated, expected, intended or planned.

Item 1.01 Entry into a Material Definitive Agreement.

Pursuant to a Note and Warrant  Purchase  Agreement dated as of October 28, 2005
by and between the Registrant and Strategic Equity Fund, LP  ("Purchaser"),  the
Company  issued and sold a secured  promissory  note  ("Note") in the  principal
amount of $660,000 CAD ($560,000 USD) to Purchaser on November 2, 2005 that pays
interest  at a rate of 2% per month.  The Note is  secured  by the  Registrant's
personal  property  presently and hereafter  owned,  subject to current security
interests.  The Note is due and  payable on April 28,  2006.  In  addition,  the
Registrant issued to Purchaser  warrants  ("Warrants") to purchase 50,000 shares
of its common stock at $0.20 per share that expire on the fifth  anniversary  of
the issuance date, and 150,000 shares of its common stock ("Common Stock").

Item 2.03 Creation of a Direct  Financial  Obligation or an Obligation  under an
Off-Balance Sheet Arrangement of a Registrant.

      (a)   Disclosure of direct financial obligation.

            (1)   On November 1, 2005,  the Registrant  became  obligated to pay
                  Purchaser amounts due under a 2% per month secured note in the
                  principal  amount of $660,000 CAD ($560,000 USD) due April 28,
                  2006.  The  details  of this Note are  described  in Item 1.01
                  listed above.

            (2)   The  principal  amount of the Note is $660,000  CAD  ($560,000
                  USD) and  interest  accrues at 2% per  month.  The Note may be
                  prepaid at any time. Interest payments of $13,200 CAD ($11,000
                  USD) shall accrue each month. If the Registrant  fails to make
                  any payment as provided herein and such failure  continues for
                  a period of 10 days after  receipt of notice of default,  then
                  the Purchaser may accelerate all payment obligations due under
                  the Note.

            (3)   Under an amendment to a Security  Agreement  dated October 28,
                  2005, the Note is secured by the personal property,  presently
                  and  hereafter   acquired,   including   without   limitation,
                  accounts,   inventory   and   receivables,   subject   to  the
                  Registrant's pre-existing security interests, subject to prior
                  security interests.  Other material provisions of the Note are
                  set forth under Item 1.01.

      (b)   Off-Balance Sheet Arrangement: None

Item 3.02 Unregistered Sale of Equity Securities.

The Company issued the Note, Common Stock and Warrants described under Item 1.01
to the  Purchaser  on November 1, 2005.  The  issuance of these  securities  was
exempt from registration under Section 4(2) of the Securities Act of 1933.
Item 5.03 Amendments to Certificate of Incorporation or Bylaws

      Pursuant to a  shareholder's  consent (14C) filed on August 26, 2005,  the
Registrant  filed  on  October  14,  2005 an  amendment  to its  Certificate  of
Incorporation to (1) increase the authorized  number of shares of Class A Common
Stock from 100,000,000 to 200,000,000,  (2) to decrease the authorized number of
shares of Class B Common Stock from 50,000,000 to 5,000,000 and (3) to leave the
authorized  number of shares of preferred  stock  unchanged at 10,000,000,  such
that the total number of authorized shares of the Corporation's capital stock is
increased from 160,000,000 to 215,000,000.

Item 8.01 Other Events.

      On  October  21,  2005,  Thomas  Quinn,   Executive  Vice  President,   US
Operations,   ceased  to  be  an  employee  of  the   Registrant.   Mr.  Quinn's
responsibilities  have been jointly assumed by Grant Johnson,  the  Registrant's
President, and Wendy Kramer, the Registrant's Vice President.

Item 9. Financial Statements and Exhibits

(a) Financial Statements of Businesses Acquired.

Not applicable.

(b) Pro Forma Financial Information

Not applicable

(c) Shell Company Transactions

Not applicable

(d) Exhibits.

Exh. No.    Description
--------    -----------

10.1.       Note and Warrant  Purchase  Agreement by and between  Registrant and
            Strategic Equity Corp. dated October 28, 2005

10.2.       Form of Secured Note

10.3.       Form of Warrant

10.4.       Security  Agreement  Amendment No. 3 by and between  Registrant  and
            Strategic Equity Corp. dated October 28, 2005
SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                        SWISS MEDICA, INC.
                                           (Registrant)

Date: November 7, 2005
                                        /s/ Bruce Fairbairn
                                        ----------------------------------
                                        Bruce Fairbairn, Chief Financial Officer